Bridgeway Capital Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-72,600
| Closed | -$37.8K | – | 1239 |
|
|
2024
Q4 | $37.8K | Sell |
72,600
-108,477
| -60% | -$56.4K | ﹤0.01% | 1165 |
|
|
2024
Q3 | $587K | Hold |
181,077
| – | – | 0.01% | 825 |
|
|
2024
Q2 | $543K | Sell |
181,077
-14,700
| -8% | -$44.1K | 0.01% | 839 |
|
|
2024
Q1 | $910K | Buy |
195,777
+25,700
| +15% | +$120K | 0.02% | 764 |
|
|
2023
Q4 | $704K | Buy |
170,077
+68,075
| +67% | +$282K | 0.02% | 849 |
|
|
2023
Q3 | $306K | Buy |
102,002
+24,302
| +31% | +$72.9K | 0.01% | 1005 |
|
|
2023
Q2 | $191K | Buy |
77,700
+45,000
| +138% | +$111K | ﹤0.01% | 1144 |
|
|
2023
Q1 | $73.9K | Buy |
+32,700
| New | +$73.9K | ﹤0.01% | 1275 |
|